🇺🇸 FDA
Pipeline program

amilo-5MER

Amilo-5MER-002

Phase 1 small_molecule completed

Quick answer

amilo-5MER for Inflammatory Disease is a Phase 1 program (small_molecule) at Galmed Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
Galmed Pharmaceuticals
Indication
Inflammatory Disease
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials